With expertise in multijurisdictional patent litigation, the team at Advokatfirman Vinge KB advises on a range of health care and life sciences mandates, and has experience working on financing, regulatory matters, and complex M&A transactions. For intellectual property matters, Håkan Borgenhäll is a key contact; he is frequently engaged in a range of trademark and marketing matters. Likewise, Malin Malm Waerme brings similar expertise, working for multinational enterprises, while Malin Ohlin is well-regarded for her commercial work within the sector. Christoffer Nordin is regularly engaged in regulatory matters, including product liability and product safety. He co-heads the team with Åsa Hellstadius.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Hakan Borgenhall is a highly experienced practitioner.'
- ‘Strong knowledge of the life sciences sector, strong firm, and strong partners.’
Key clients
- Eli Lilly and Company
- Bridgepoint Growth
- Fidelio Capital
- Recipharm AB (publ)
- Atlas Antibodies AB
- Tamro AB
- Vimian Group AB (publ)
- Corline Biomedical AB (publ)
- Medivir AB (publ)
- Xspray Pharma AB (publ)
- Hansa Biopharma AB
- Calliditas Therapeutics AB (publ)
Work highlights
Representing Merck Sharp & Dohme in a dispute where KRKA has initiated an invalidity action against one of MSD’s supplementary protection certificates (“SPC”) for its anti-diabetic drug Janumet®.
Advising Takeda on three interrelated SPC disputes concerning an ADHD treatment, including an infringement case against Sandoz and two validity actions involving STADA and Teva.
Practice head
Åsa Hellstadius; Christoffer Nordin
Other key lawyers
Håkan Borgenhäll; Malin Malm Waerme; Malin Ohlin